Bolt Biotherapeutics, Inc. Deferred Costs, Noncurrent
Bolt Biotherapeutics, Inc. (BOLT) had Deferred Costs, Noncurrent of $2.36 million as of 2020-12-31, per its 10-K filed 2022-03-30.
Discontinued › Balance Sheet › Assets, Noncurrent
us-gaap:DeferredCosts · last filed 2022-03-30
- 2020-12-31: Deferred Costs, Noncurrent $2.36M.
| Period end | Deferred Costs, Noncurrent |
|---|---|
| 2020-12-31 | $2.36M 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |